| rs2253319 |
chr21 |
36188046 |
0.000296 |
C |
T |
Nicotine smoking |
RUNX1 |
intron |
19268276
|
| rs9976946 |
chr21 |
36208062 |
0.00051 |
C |
T |
Multiple complex diseases |
RUNX1 |
intron |
17554300
|
| rs9976946 |
chr21 |
36208062 |
0.000005 |
C |
T |
Preeclampsia |
RUNX1 |
intron |
23551011
|
| rs2834649 |
chr21 |
36209650 |
0.000631 |
G |
A |
Nicotine smoking |
RUNX1 |
intron |
19268276
|
| rs2834650 |
chr21 |
36210100 |
0.000278 |
C |
T |
Multiple complex diseases |
RUNX1 |
intron |
17554300
|
| rs2186290 |
chr21 |
36219716 |
0.0006643 |
T |
G |
Anti-TNF treatment response in rheumatoid arthritis (by DAS-28 score change at 3 months) |
RUNX1 |
intron |
23233654
|
| rs2186290 |
chr21 |
36219716 |
0.000664 |
T |
G |
Methotrexate clearance (acute lymphoblastic leukemia) |
RUNX1 |
intron |
23233662
|
| rs2268284 |
chr21 |
36220679 |
0.0000478 |
T |
C |
Anti-TNF treatment response in rheumatoid arthritis (by DAS-28 score change at 3 months) |
RUNX1 |
intron |
23233654
|
| rs2268284 |
chr21 |
36220679 |
0.0000478 |
T |
C |
Methotrexate clearance (acute lymphoblastic leukemia) |
RUNX1 |
intron |
23233662
|
| rs2409535 |
chr21 |
36222560 |
0.0006647 |
T |
C |
Anti-TNF treatment response in rheumatoid arthritis (by DAS-28 score change at 3 months) |
RUNX1 |
intron |
23233654
|
| rs2409535 |
chr21 |
36222560 |
0.000665 |
T |
C |
Methotrexate clearance (acute lymphoblastic leukemia) |
RUNX1 |
intron |
23233662
|
| rs968625 |
chr21 |
36223627 |
0.0000159 |
G |
A |
Major depressive disorder |
RUNX1 |
intron |
19107115
|
| rs2834655 |
chr21 |
36238507 |
0.0000005 |
G |
A |
Immune response to smallpox vaccine (IL-6) |
RUNX1 |
intron |
22542470
|
| rs13053063 |
chr21 |
36255821 |
0.000028 |
T |
G |
Urinary metabolites |
RUNX1 |
intron |
21572414
|
| rs2834664 |
chr21 |
36275439 |
0.0002 |
T |
C |
Cognitive impairment induced by topiramate |
RUNX1 |
intron |
22091778
|
| rs9985174 |
chr21 |
36277558 |
0.00079 |
T |
A |
Atrial fibrillation |
RUNX1 |
intron |
21846873
|
| rs2834669 |
chr21 |
36280043 |
0.00021 |
A |
G |
Coronary artery calcification |
RUNX1 |
intron |
23727086
|
| rs2834670 |
chr21 |
36280376 |
0.000343 |
A |
G |
Blood pressure,CVD RF and other traits (body mass index (BMI),waist:hip ratio,renin activity in plasma,aldosterone concentration in plasma,BNP levels in plasma,alcohol consumption) |
RUNX1 |
intron |
20877124
|
| rs9984470 |
chr21 |
36285911 |
0.000014 |
C |
T |
Iron levels |
RUNX1 |
intron |
21208937
|
| rs2834672 |
chr21 |
36289022 |
0.000864 |
G |
A |
Insulin resistance |
RUNX1 |
intron |
21901158
|
| rs2834680 |
chr21 |
36309463 |
0.000517 |
T |
C |
Stroke |
RUNX1 |
intron |
pha002887
|
| rs8126567 |
chr21 |
36313618 |
0.0000054 |
C |
T |
Iron levels |
RUNX1 |
intron |
21208937
|
| rs11701453 |
chr21 |
36338916 |
0.000000165 |
C |
G |
Dilated cardiomyopathy |
RUNX1 |
intron |
20975947
|
| rs11701555 |
chr21 |
36339264 |
0.0000738 |
G |
A |
Cholesterol |
RUNX1 |
intron |
17255346
|
| rs11701555 |
chr21 |
36339264 |
0.000031 |
G |
A |
Salmonella-induced pyroptosis |
RUNX1 |
intron |
22837397
|
| rs2014300 |
chr21 |
36357861 |
8e-22 |
A |
G |
Esophageal cancer |
RUNX1 |
intron |
21642993
|
| rs2242876 |
chr21 |
36362546 |
0.00000136 |
C |
A |
Cholesterol,total |
RUNX1 |
intron |
23063622
|
| rs7282535 |
chr21 |
36377221 |
0.000168 |
A |
T |
Nicotine smoking |
RUNX1 |
intron |
19268276
|
| rs2242888 |
chr21 |
36387828 |
0.00054 |
T |
C |
Type 2 diabetes |
RUNX1 |
intron |
17463246
|
| rs882776 |
chr21 |
36388287 |
0.000918 |
C |
T |
Type 2 diabetes |
RUNX1 |
intron |
17463246
|
| rs1474479 |
chr21 |
36405666 |
0.000818 |
C |
T |
Type 2 diabetes |
RUNX1 |
intron |
17463246
|
| rs9980210 |
chr21 |
36406550 |
0.000461 |
T |
C |
Type 2 diabetes |
RUNX1 |
intron |
17463246
|
| rs2294163 |
chr21 |
36407390 |
0.000732 |
G |
A |
Amyotrophic lateral sclerosis (sporadic) |
RUNX1 |
intron |
24529757
|
| rs9983044 |
chr21 |
36416332 |
0.0000002 |
C |
G |
Phospholipid levels (plasma) |
RUNX1 |
intron |
21829377
|
| rs2071029 |
chr21 |
36422478 |
0.0000081 |
C |
T |
Urinary metabolites |
RUNX1 |
nearGene-5 |
21572414
|